FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Busse Hospital Recalls Tracheostomy Tray Kits

Busse Hospital Disposables recalls its Tracheostomy Care Tray, Dressing Change Tray, and Tracheostomy Care Set in response to Nurse Assists 11/2023 re...

latest-news-card-1
Federal Register

Draft Guide on ANDA Reconsideration

Federal Register notice: FDA makes available a draft guidance entitled Requests for Reconsideration at the Division Level Under GDUFA.

latest-news-card-1
Federal Register

Info Collection on E-Records/E-Signatures

Federal Register notice: FDA sends to OMB an information collection revision entitled Electronic Records; Electronic Signatures 21 CFR Part 11.

latest-news-card-1
Human Drugs

CGMP Violations at Woorilife & Health

FDA warns South Koreas Woorilife & Health about CGMP violations in its manufacturing of over-the-counter drugs.

latest-news-card-1
Medical Devices

MDR Violations at Neitz Instruments

FDA warns Ichibancho, Japan-based Neitz Instruments Company about Medical Device Reporting violations in its manufacturing of its halogen ophthalmosco...

latest-news-card-1
Human Drugs

Objectionable Conditions in Childrens Hospital Trials

FDA warns Dr. Jeffrey Taub and the Childrens Hospital of Michigan about objectionable conditions in two clinical investigations.

latest-news-card-1
Human Drugs

Mixed State Court Decision in Tenofovir Case

A California appeals court affirms in part and reverses in part a trial court decision in a case involving negligence claims against Gilead over its H...

latest-news-card-1
Human Drugs

Revised GDUFA Request for Reconsideration Guide

FDA publishes a draft guidance on requesting reconsideration of ANDA decisions to reflect the current GDUFA reauthorization.

latest-news-card-1
Human Drugs

CTTI Sees Barriers to Trial Reporting

In a project conducted with FDA, the Clinical Trials Transformation Institute identifies barriers to timely and complete reporting of clinical trials ...

latest-news-card-1
Human Drugs

Guide on Sterility Info in 510(k) Submissions

FDA revises its guidance entitled Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as...